Skip to main content

Advertisement

SpringerLink
Log in

Tuberous Sclerosis Complex: a Case Study

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

The article is a contribution to the international database of tuberous sclerosis case studies. As tuberous sclerosis complex (Bourneville–Pringle disease) is a rare genetically determined polysystemic disease, each clinical case is very significant. The first clinical symptoms of the disease usually appear immediately after birth, but they differ in significant polymorphism and affect brain, different organs, and systems, including changes in the skin, nervous system, eyes, and inner organs. Accurate diagnosis of tuberous sclerosis is fundamental to proper medical supervision and treatment. The article describes modern genetic and clinical criteria of diagnosis in detail; the specificity of the clinical case and problems emerged during follow-up of the patient, diagnostic errors, and findings. The author proves the importance of a multidisciplinary approach not only in diagnosis but also in the treatment of tuberous sclerosis including neuropsychological approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006). The tuberous sclerosis complex. The New England journal of medicine., 355(13), 1345–1356.

    Article  Google Scholar 

  2. Tuberous sclerosis (2012) / Edited by M.Yu.Dorofeeva. Moscow: Practical Medicine, 240 p.

  3. Grigore, I., Diaconu, G., Burlea, M., Ignat, A., Luca, E., & Lupu, V. V. (2017). Clinical characteristics and treatment of epilepsy in children with tuberous sclerosis complex. E-Health and Bioengineering Conference, 149–152.

  4. Osborne, J. P., Fryer, A., & Webb, D. (1991). Epidemiology of tuberous sclerosis. Annals of the New York Academy of Sciences. 1991, 615, 125–128.

    Article  Google Scholar 

  5. Kwiatkowski, D. J., Reeve, M. P., Cheadle, J. P., & Sampson, J. R. (2003). Tuberous Sclerosis complex: from Basic Science to Clinical Phenotypes. In Molecular Genetics (pp. 228–263). London, England: Mac Keith Press.

    Google Scholar 

  6. Dorofeeva, M. Y., & Belousova, E. D. (2012). The possibilities of pathogenetic therapy of tuberous sclerosis. Effective pharmacotherapy. Pediatria., 4, 50–58.

    Google Scholar 

  7. Chtourou, O., Ezzine Sebai, N., Fazaa, B., Zeglaoui, F., Kharfi, M., Kamoun, M.R. Tuberous sclerosis (19 cases) [La sclérose tubéreuse de Bourneville. A propos de 19 cas] (2005). Dermatologia Clinica 25(1): 54–57.

  8. Cichoń-Mikołajczyk, A., Podwińska, E., Smietana, J., & Słota, P. (2006). Bourneville-Pringle disease. Case report [Choroba Bourneville'a-Pringle'a. Opis przypadku]. Przegla̧d lekarski., 63(2), 104–105.

    Google Scholar 

  9. Mimura, S., Kikura, M., Itagaki, T., Hirano, K., & Sato, S. (2006). A case of a pediatric patient with tuberous sclerosis (Bourneville-Pringle disease) and frequent epileptic seizure for intensive dental treatment under general anesthesia. Japanese Journal of Anesthesiology, 55(4), 471–474.

    Google Scholar 

  10. Dyrla, P., Wojtuń, S., Gil, J., Jałocha, Ł., Wojtkowiak, M., & Błaszak, A. (2008). Morbus Bourneville-Pringle—case report [Choroba Bourneville'a-Pringle'a - Opis przypadku]. Pediatria i Medycyna Rodzinna, 4(3), 189–194.

    Google Scholar 

  11. Sofoudis, C., Kalampokas, T., Boutas, I., Kalampokas, E., & Salakos, N. (2014). Morbus Burneville: a case report and review of the literature. Clinical and Experimental Obstetrics and Gynecology, 41(1), 95–97.

    Google Scholar 

  12. Krueger, D. A., & Northrup, H. (2013). The International Tuberous Sclerosis Complex Consensus Group. Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatric Neurology, 49, 255–265.

    Article  Google Scholar 

  13. Gamirova, R. G., Shaimardanova, R. M., & Ziganshina, L. E. (2012). Pharmacoepidemiology of antiepileptic drugs in children: Comparative analysis of efficacy and safety. International Journal of Risk and Safety in Medicine, 24(3), 179–185.

    Google Scholar 

  14. Farnosova, M. E., & Gamirova, R. G. (2017). Comparative analysis of therapy outcomes in patients with west syndrome receiving tetracosactide and other antiepileptic drugs. Russkii Zhunal Detskoi Nevrologii., 12(3), 44–50.

    Google Scholar 

  15. Esin R., Gorobets E., Tokareva N., Karimullina R., Khairullin I., Mingazova L. (2014). Diagnostic criteria for dementia, moderate and mild neurocognitive disorders in neurological patients: linguistic parts of baseline neurocognitive tests. SGEM Conference on Psychology & Psychiatry, Sociology & Healthcare, Education: Conference Proceedings (Bulgaria, International Multidisciplinary Scientific Conferences on Social Sciences and Arts, 3–9 September 2014). Bulgaria, 2014. 1: 121–128.

  16. Gamirova R.G., Gorobets E.A., Marulina V.I., Bolshakova T.A., Zaykova F.M. (2017). Developmental disorders in children with cognitive epileptiform disintegration. 4th International Multidisciplinary Scientific Conferences on Social Sciences & Arts SGEM 2017. 2: 107–115.

  17. Mennel, S., Meyer, C. H., Eggarter, F., & Peter, S. (2005). Autofluorescence and angiographic findings of retinal astrocytic hamartomas in tuberous sclerosis. Ophthalmologica, 219(6), 350–356.

    Article  Google Scholar 

  18. Yusupova, L. A., Garaeva, Z. S., Yunusova, E. I., Mavlutova, G. I., Khaertdinova, L. A., Galikhanova, E. E., & Rokitskaya, V. N. (2012). Bourneville-Pringle disease. General Practitionner., 10, 18–21.

    Google Scholar 

  19. Voykov, B., Guenova, E., Süsskind, D., & Schiefer, U. (2007). Tuberous sclerosis: an interdisciplinary diagnosis [Tuberöse sklerose: Eine interdisziplinäre diagnose]. Klinische Monatsblatter fur Augenheilkunde, 224(5), 441–444.

    Article  Google Scholar 

Download references

Acknowledgements

The reported study was supported by the program of competitive growth of Kazan Federal University.

Author information

Authors and Affiliations

  1. Laboratory of Clinical Linguistics, Kazan Federal University, Tatarstan str., Kazan, 420008, Russia

    Rimma Gamirova

  2. Department of Pediatric Neurology, Kazan State Medical Academy, 11 Mushtari str., Kazan, 420012, Russia

    Rimma Gamirova

  3. Department of Fundamental Basis of Clinical Medicine, Kazan Federal University, 76 K.Marks str., Kazan, 420012, Russia

    Rimma Gamirova

Authors
  1. Rimma Gamirova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rimma Gamirova.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gamirova, R. Tuberous Sclerosis Complex: a Case Study. BioNanoSci. 8, 859–863 (2018). https://doi.org/10.1007/s12668-018-0541-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-018-0541-4

Keywords

Search

Navigation